Related Experiment Videos
Acute myocardial infarction after sumatriptan administration for cluster headache.
E Anghileri1, V Toso, F Perini
1UOC di Neurologia, Ospedale S. Bortolo, ULSS 6, Vicenza, Italy.
Summary
Sumatriptan effectively treats cluster headache pain but can rarely cause heart attacks, even in patients without prior heart disease. Indomethacin provided an alternative treatment during a myocardial infarction event.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Cluster headache is characterized by severe pain, often treated with sumatriptan.
- Sumatriptan, a common treatment, carries a rare risk of serious cardiovascular events.
- These events are typically associated with pre-existing cardiovascular risk or disease.
Observation:
- A 42-year-old male with episodic cluster headache and no history of coronary artery disease experienced acute myocardial infarction.
- The myocardial infarction occurred three hours after subcutaneous sumatriptan injection.
- During hospitalization, cluster headache attacks were managed effectively with intravenous indomethacin.
Findings:
- This case highlights a rare instance of sumatriptan-induced myocardial infarction in a patient without apparent cardiovascular risk factors.
- The successful management of cluster headache with intravenous indomethacin suggests an alternative therapeutic option.
Implications:
- Clinicians should remain vigilant for potential cardiovascular risks associated with sumatriptan, even in younger patients without known heart disease.
- Exploring alternative treatments like indomethacin is crucial for managing cluster headaches in patients with contraindications or adverse events to standard therapies.